Concepts (225)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Radiography, Interventional | 8 | 2018 | 88 | 2.260 |
Why?
|
| Venous Thrombosis | 9 | 2021 | 170 | 2.050 |
Why?
|
| Catheterization, Central Venous | 4 | 2024 | 139 | 1.940 |
Why?
|
| Thrombolytic Therapy | 7 | 2021 | 216 | 1.520 |
Why?
|
| Ureteral Obstruction | 4 | 2023 | 105 | 1.350 |
Why?
|
| Ultrasonography, Interventional | 7 | 2018 | 207 | 1.080 |
Why?
|
| Tissue Plasminogen Activator | 3 | 2021 | 121 | 1.010 |
Why?
|
| Yttrium Radioisotopes | 3 | 2021 | 19 | 0.980 |
Why?
|
| Radiology, Interventional | 3 | 2022 | 35 | 0.960 |
Why?
|
| Endovascular Procedures | 6 | 2016 | 784 | 0.920 |
Why?
|
| Catheterization, Peripheral | 4 | 2022 | 131 | 0.890 |
Why?
|
| Femoral Vein | 3 | 2024 | 48 | 0.890 |
Why?
|
| Mechanical Thrombolysis | 2 | 2015 | 10 | 0.880 |
Why?
|
| Embolization, Therapeutic | 4 | 2021 | 225 | 0.870 |
Why?
|
| Kidney Transplantation | 2 | 2023 | 569 | 0.800 |
Why?
|
| Vesico-Ureteral Reflux | 1 | 2023 | 87 | 0.740 |
Why?
|
| Ureter | 1 | 2023 | 99 | 0.720 |
Why?
|
| Jugular Veins | 2 | 2020 | 76 | 0.690 |
Why?
|
| Catheters, Indwelling | 2 | 2024 | 157 | 0.690 |
Why?
|
| Cannula | 1 | 2020 | 31 | 0.670 |
Why?
|
| Child | 35 | 2024 | 25823 | 0.660 |
Why?
|
| Device Removal | 2 | 2013 | 225 | 0.660 |
Why?
|
| Central Venous Catheters | 2 | 2022 | 48 | 0.630 |
Why?
|
| Adolescent | 28 | 2024 | 20552 | 0.600 |
Why?
|
| Liver Neoplasms | 5 | 2021 | 1394 | 0.600 |
Why?
|
| Solitary Pulmonary Nodule | 1 | 2018 | 30 | 0.550 |
Why?
|
| Lower Extremity | 2 | 2021 | 188 | 0.530 |
Why?
|
| Tomography, X-Ray Computed | 4 | 2020 | 2169 | 0.530 |
Why?
|
| Stents | 5 | 2024 | 873 | 0.520 |
Why?
|
| Carcinoma, Hepatocellular | 3 | 2021 | 990 | 0.520 |
Why?
|
| Extracorporeal Membrane Oxygenation | 2 | 2020 | 657 | 0.520 |
Why?
|
| Medical Errors | 1 | 2018 | 161 | 0.510 |
Why?
|
| Infant | 18 | 2024 | 13192 | 0.500 |
Why?
|
| Fibrinolytic Agents | 2 | 2016 | 206 | 0.490 |
Why?
|
| Catheter-Related Infections | 1 | 2018 | 137 | 0.490 |
Why?
|
| Child, Preschool | 16 | 2024 | 14853 | 0.480 |
Why?
|
| Pediatrics | 2 | 2018 | 1215 | 0.470 |
Why?
|
| Outpatients | 1 | 2017 | 275 | 0.460 |
Why?
|
| Monitoring, Physiologic | 1 | 2017 | 380 | 0.450 |
Why?
|
| Upper Extremity Deep Vein Thrombosis | 1 | 2014 | 3 | 0.440 |
Why?
|
| Retrospective Studies | 20 | 2024 | 17363 | 0.410 |
Why?
|
| Male | 34 | 2024 | 65054 | 0.390 |
Why?
|
| Ultrasonography | 3 | 2024 | 988 | 0.390 |
Why?
|
| Catheterization | 2 | 2011 | 240 | 0.380 |
Why?
|
| Humans | 50 | 2024 | 132336 | 0.380 |
Why?
|
| Lung Neoplasms | 2 | 2021 | 1541 | 0.360 |
Why?
|
| Vena Cava Filters | 1 | 2011 | 19 | 0.350 |
Why?
|
| Iliac Vein | 2 | 2024 | 29 | 0.340 |
Why?
|
| Biliary Tract Diseases | 1 | 2010 | 37 | 0.340 |
Why?
|
| Veins | 1 | 2011 | 101 | 0.340 |
Why?
|
| Female | 31 | 2024 | 70788 | 0.330 |
Why?
|
| Venous Thromboembolism | 2 | 2024 | 186 | 0.330 |
Why?
|
| Punctures | 4 | 2024 | 62 | 0.320 |
Why?
|
| Infant, Newborn | 8 | 2018 | 8566 | 0.320 |
Why?
|
| Liver | 1 | 2017 | 1815 | 0.320 |
Why?
|
| Lymphatic Diseases | 1 | 2009 | 31 | 0.300 |
Why?
|
| Treatment Outcome | 15 | 2024 | 13016 | 0.300 |
Why?
|
| Popliteal Artery | 1 | 2009 | 41 | 0.300 |
Why?
|
| Pulmonary Embolism | 1 | 2011 | 189 | 0.300 |
Why?
|
| Intermittent Claudication | 1 | 2009 | 59 | 0.290 |
Why?
|
| Angiography, Digital Subtraction | 4 | 2020 | 52 | 0.290 |
Why?
|
| Vena Cava, Inferior | 2 | 2021 | 104 | 0.280 |
Why?
|
| Arachnoid Cysts | 1 | 2007 | 7 | 0.270 |
Why?
|
| Epidermal Cyst | 1 | 2007 | 18 | 0.270 |
Why?
|
| Nephrolithiasis | 2 | 2018 | 15 | 0.270 |
Why?
|
| Spinal Cord Diseases | 1 | 2007 | 35 | 0.260 |
Why?
|
| Postoperative Complications | 2 | 2021 | 3139 | 0.260 |
Why?
|
| Portal Vein | 2 | 2017 | 91 | 0.250 |
Why?
|
| Cysts | 2 | 2024 | 97 | 0.250 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2007 | 154 | 0.240 |
Why?
|
| Vascular Surgical Procedures | 1 | 2011 | 550 | 0.240 |
Why?
|
| Urography | 1 | 2005 | 32 | 0.240 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2009 | 3853 | 0.240 |
Why?
|
| Radiation Dosage | 3 | 2015 | 146 | 0.230 |
Why?
|
| Practice Guidelines as Topic | 2 | 2013 | 1305 | 0.230 |
Why?
|
| Urologic Diseases | 1 | 2005 | 45 | 0.230 |
Why?
|
| Time Factors | 6 | 2017 | 6455 | 0.230 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 2 | 2015 | 53 | 0.230 |
Why?
|
| Head and Neck Neoplasms | 1 | 2009 | 615 | 0.210 |
Why?
|
| Anticoagulants | 4 | 2022 | 607 | 0.200 |
Why?
|
| Liver Transplantation | 2 | 2016 | 1103 | 0.200 |
Why?
|
| Muscle, Skeletal | 1 | 2009 | 1042 | 0.190 |
Why?
|
| Constriction, Pathologic | 1 | 2023 | 235 | 0.180 |
Why?
|
| Models, Animal | 2 | 2014 | 471 | 0.180 |
Why?
|
| May-Thurner Syndrome | 1 | 2021 | 4 | 0.180 |
Why?
|
| Giant Cell Tumor of Bone | 1 | 2021 | 7 | 0.180 |
Why?
|
| Denosumab | 1 | 2021 | 14 | 0.170 |
Why?
|
| Bone Density Conservation Agents | 1 | 2021 | 56 | 0.170 |
Why?
|
| Renal Artery Obstruction | 1 | 2020 | 42 | 0.170 |
Why?
|
| Lymphangioma | 1 | 2020 | 24 | 0.170 |
Why?
|
| Phlebography | 3 | 2016 | 43 | 0.170 |
Why?
|
| Lymphatic Vessels | 1 | 2020 | 36 | 0.170 |
Why?
|
| Teratoma | 1 | 2021 | 130 | 0.160 |
Why?
|
| Fluoroscopy | 2 | 2017 | 100 | 0.160 |
Why?
|
| Nephrostomy, Percutaneous | 2 | 2017 | 21 | 0.150 |
Why?
|
| Drainage | 2 | 2011 | 265 | 0.150 |
Why?
|
| Femoral Artery | 1 | 2020 | 167 | 0.150 |
Why?
|
| Hepatoblastoma | 1 | 2021 | 182 | 0.150 |
Why?
|
| Fused Kidney | 1 | 2018 | 3 | 0.150 |
Why?
|
| Radiographic Image Enhancement | 2 | 2015 | 45 | 0.150 |
Why?
|
| Young Adult | 7 | 2021 | 9945 | 0.150 |
Why?
|
| Muscular Atrophy, Spinal | 1 | 2018 | 47 | 0.140 |
Why?
|
| Oligonucleotides | 1 | 2018 | 95 | 0.140 |
Why?
|
| Methylene Blue | 1 | 2018 | 16 | 0.140 |
Why?
|
| Thoracic Surgery, Video-Assisted | 1 | 2018 | 56 | 0.140 |
Why?
|
| Iatrogenic Disease | 1 | 2018 | 131 | 0.140 |
Why?
|
| Feasibility Studies | 3 | 2016 | 826 | 0.140 |
Why?
|
| Ureterostomy | 1 | 2017 | 6 | 0.140 |
Why?
|
| Kidney Pelvis | 1 | 2017 | 46 | 0.140 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2021 | 1303 | 0.140 |
Why?
|
| Splenic Artery | 1 | 2017 | 22 | 0.140 |
Why?
|
| Dwarfism | 1 | 2018 | 104 | 0.130 |
Why?
|
| Patient Care Planning | 1 | 2018 | 130 | 0.130 |
Why?
|
| Thrombosis | 1 | 2022 | 529 | 0.130 |
Why?
|
| Image-Guided Biopsy | 1 | 2017 | 44 | 0.130 |
Why?
|
| Ovarian Neoplasms | 1 | 2021 | 463 | 0.130 |
Why?
|
| Thrombectomy | 2 | 2014 | 111 | 0.130 |
Why?
|
| Biopsy, Needle | 1 | 2017 | 234 | 0.130 |
Why?
|
| Sensitivity and Specificity | 5 | 2020 | 2145 | 0.130 |
Why?
|
| Equipment Design | 3 | 2013 | 605 | 0.130 |
Why?
|
| Portasystemic Shunt, Transjugular Intrahepatic | 1 | 2016 | 18 | 0.130 |
Why?
|
| Bone Neoplasms | 1 | 2021 | 445 | 0.120 |
Why?
|
| Equipment Failure Analysis | 2 | 2013 | 86 | 0.120 |
Why?
|
| Liver Cirrhosis, Biliary | 1 | 2016 | 88 | 0.120 |
Why?
|
| Cone-Beam Computed Tomography | 1 | 2015 | 23 | 0.120 |
Why?
|
| Esophageal and Gastric Varices | 1 | 2016 | 76 | 0.120 |
Why?
|
| Anesthesia | 1 | 2018 | 208 | 0.120 |
Why?
|
| Lithotripsy | 1 | 2015 | 30 | 0.120 |
Why?
|
| Hypertension, Portal | 1 | 2016 | 78 | 0.120 |
Why?
|
| Urogenital Abnormalities | 1 | 2017 | 167 | 0.120 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2015 | 65 | 0.120 |
Why?
|
| Microcephaly | 1 | 2018 | 354 | 0.120 |
Why?
|
| Prognosis | 2 | 2021 | 5009 | 0.110 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2016 | 237 | 0.110 |
Why?
|
| Radiation Protection | 1 | 2014 | 58 | 0.110 |
Why?
|
| Combined Modality Therapy | 2 | 2014 | 1297 | 0.100 |
Why?
|
| Radiation Monitoring | 1 | 2013 | 16 | 0.100 |
Why?
|
| Vascular Patency | 1 | 2014 | 187 | 0.100 |
Why?
|
| X-Ray Intensifying Screens | 1 | 2013 | 3 | 0.100 |
Why?
|
| Adenoma, Liver Cell | 1 | 2013 | 4 | 0.100 |
Why?
|
| Hemorrhage | 1 | 2017 | 517 | 0.100 |
Why?
|
| Kidney | 1 | 2020 | 1331 | 0.100 |
Why?
|
| Robotic Surgical Procedures | 1 | 2017 | 218 | 0.100 |
Why?
|
| Iodine | 1 | 2013 | 25 | 0.100 |
Why?
|
| Angiography | 2 | 2015 | 209 | 0.100 |
Why?
|
| Liver Diseases | 1 | 2017 | 387 | 0.100 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2015 | 390 | 0.100 |
Why?
|
| Medical Staff, Hospital | 1 | 2013 | 96 | 0.100 |
Why?
|
| Angioplasty, Balloon | 1 | 2014 | 159 | 0.100 |
Why?
|
| Infusions, Intravenous | 1 | 2014 | 558 | 0.100 |
Why?
|
| Syndrome | 2 | 2021 | 1171 | 0.100 |
Why?
|
| Contrast Media | 3 | 2020 | 508 | 0.100 |
Why?
|
| Gadolinium | 1 | 2013 | 116 | 0.100 |
Why?
|
| Hospitals, Pediatric | 2 | 2016 | 781 | 0.100 |
Why?
|
| Occupational Exposure | 1 | 2013 | 131 | 0.090 |
Why?
|
| Laparoscopy | 1 | 2017 | 522 | 0.090 |
Why?
|
| Upper Extremity | 1 | 2012 | 55 | 0.090 |
Why?
|
| Brachytherapy | 1 | 2012 | 95 | 0.090 |
Why?
|
| Atrioventricular Block | 1 | 2012 | 46 | 0.090 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2017 | 1010 | 0.090 |
Why?
|
| Cholangiography | 1 | 2010 | 15 | 0.090 |
Why?
|
| Age Factors | 2 | 2016 | 2931 | 0.090 |
Why?
|
| Abdominal Abscess | 1 | 2011 | 27 | 0.090 |
Why?
|
| Biliary Tract | 1 | 2010 | 13 | 0.090 |
Why?
|
| Dilatation | 1 | 2011 | 71 | 0.080 |
Why?
|
| Heart | 1 | 2015 | 699 | 0.080 |
Why?
|
| Catheter Ablation | 1 | 2013 | 241 | 0.080 |
Why?
|
| Catheters | 1 | 2011 | 89 | 0.080 |
Why?
|
| Diagnostic Imaging | 1 | 2012 | 315 | 0.080 |
Why?
|
| Pacemaker, Artificial | 1 | 2012 | 183 | 0.080 |
Why?
|
| Head | 1 | 2009 | 115 | 0.070 |
Why?
|
| Risk Factors | 2 | 2014 | 10910 | 0.070 |
Why?
|
| Neck | 1 | 2009 | 142 | 0.070 |
Why?
|
| Lymphatic Metastasis | 1 | 2009 | 443 | 0.070 |
Why?
|
| Cohort Studies | 1 | 2017 | 5150 | 0.070 |
Why?
|
| Lymph Nodes | 1 | 2009 | 388 | 0.070 |
Why?
|
| Recurrence | 2 | 2024 | 1458 | 0.060 |
Why?
|
| Follow-Up Studies | 2 | 2017 | 5405 | 0.060 |
Why?
|
| Prospective Studies | 3 | 2022 | 6540 | 0.060 |
Why?
|
| Gadolinium DTPA | 1 | 2005 | 49 | 0.060 |
Why?
|
| Angioplasty | 2 | 2016 | 76 | 0.060 |
Why?
|
| Reproducibility of Results | 3 | 2015 | 3022 | 0.050 |
Why?
|
| Ohio | 2 | 2013 | 87 | 0.050 |
Why?
|
| Adult | 5 | 2021 | 31618 | 0.040 |
Why?
|
| Swine | 2 | 2015 | 1197 | 0.040 |
Why?
|
| Diagnosis, Differential | 1 | 2007 | 1964 | 0.040 |
Why?
|
| Lymphatic System | 1 | 2020 | 19 | 0.040 |
Why?
|
| Hepatectomy | 1 | 2021 | 124 | 0.040 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2021 | 399 | 0.040 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2020 | 165 | 0.040 |
Why?
|
| Computed Tomography Angiography | 1 | 2020 | 215 | 0.040 |
Why?
|
| Consensus | 1 | 2022 | 656 | 0.040 |
Why?
|
| Nephrolithotomy, Percutaneous | 1 | 2018 | 5 | 0.040 |
Why?
|
| Risk Assessment | 2 | 2017 | 3710 | 0.030 |
Why?
|
| Disease Management | 1 | 2021 | 565 | 0.030 |
Why?
|
| Portography | 1 | 2016 | 2 | 0.030 |
Why?
|
| Portal Pressure | 1 | 2016 | 5 | 0.030 |
Why?
|
| Postthrombotic Syndrome | 1 | 2016 | 2 | 0.030 |
Why?
|
| Disease-Free Survival | 1 | 2018 | 956 | 0.030 |
Why?
|
| Fatty Liver | 1 | 2018 | 212 | 0.030 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2017 | 193 | 0.030 |
Why?
|
| Retreatment | 1 | 2016 | 92 | 0.030 |
Why?
|
| X-Rays | 1 | 2015 | 31 | 0.030 |
Why?
|
| Needles | 1 | 2015 | 51 | 0.030 |
Why?
|
| Scattering, Radiation | 1 | 2015 | 58 | 0.030 |
Why?
|
| Risk | 1 | 2017 | 763 | 0.030 |
Why?
|
| Tertiary Care Centers | 1 | 2016 | 260 | 0.030 |
Why?
|
| Phantoms, Imaging | 1 | 2015 | 147 | 0.030 |
Why?
|
| Wireless Technology | 1 | 2013 | 13 | 0.030 |
Why?
|
| Occupational Injuries | 1 | 2013 | 12 | 0.030 |
Why?
|
| Survival Rate | 1 | 2018 | 2187 | 0.030 |
Why?
|
| Aged | 2 | 2016 | 21379 | 0.020 |
Why?
|
| Animals | 4 | 2015 | 34989 | 0.020 |
Why?
|
| Feedback | 1 | 2013 | 167 | 0.020 |
Why?
|
| Subclavian Vein | 1 | 2012 | 21 | 0.020 |
Why?
|
| Rabbits | 1 | 2013 | 688 | 0.020 |
Why?
|
| Radiation Injuries | 1 | 2013 | 158 | 0.020 |
Why?
|
| Radiopharmaceuticals | 1 | 2012 | 169 | 0.020 |
Why?
|
| Middle Aged | 2 | 2016 | 28888 | 0.020 |
Why?
|
| Guideline Adherence | 1 | 2013 | 395 | 0.020 |
Why?
|
| Pelvis | 1 | 2011 | 72 | 0.020 |
Why?
|
| Rectum | 1 | 2011 | 114 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2013 | 1669 | 0.020 |
Why?
|
| Pregnancy | 1 | 2017 | 7567 | 0.010 |
Why?
|
| United States | 1 | 2016 | 11628 | 0.010 |
Why?
|